Blog: We have the public to thank for this week’s well-informed decisions in health research

We have had two pieces of good news about health research of patient benefit this week. First, the National Institute for Health and Care Excellence (NICE) issued new guidance saying that tamoxifen or raloxifene taken daily for five years can cut breast cancer risk by 40%.  This means women at risk of developing breast cancer have... Continue Reading →

Dame Sally Davies interview in the FT

Dame Sally Davies, England's new Chief Medical Officer, gives a frank and open interview in today's Financial Times.  In it, Dame Sally says that she will continue to play a leadership role with respect to NHS R&D but with perhaps less involvement in the day-to-day running (my interpretation).

NIHR Funding Announcement and hats-off to Diabetes UK

The UK National Institute for Health Research (NIHR) has today announced £775 million worth of funding over five years for translational research.  The funding will be made available through NIHR to NHS/university partnerships. Also, in what has to be an exemplar for others in terms of dissemination, Diabetes UK have today made a very public... Continue Reading →

Blog at WordPress.com.

Up ↑

%d bloggers like this: